Scientists from UNIGE have developed synthetic molecules that mimic antibodies. They could revolutionize the treatment of ...

Galux Inc., a South Korean startup specializing in AI-driven protein therapeutics design, has published a study showcasing ...

Researchers have identified antibodies that could lead to a broadly protective norovirus vaccine and new treatment options.

VUMC received up to $30M to develop AI for antibody therapy discovery, aiming to create an antibody-antigen atlas and identify therapeutic antibodies.

Next, the researchers will work to design bispecific antibodies that would be effective against all coronaviruses, the virus family including the ones that cause the common cold, MERS, and COVID-19.

Identifying antibodies for 75% of norovirus outbreaks, University researchers took a step forward in creating a vaccine for ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety ...

This research marks an important milestone in AI-driven antibody discovery, demonstrating the successful design of antibodies against six distinct therapeutic targets, including a target without ...